Medtronic plc announced four-year results from the Evolut Low Risk Trial. The Medtronic Evolut? transcatheter aortic valve replacement system demonstrated exceptional outcomes and sustained valve...
Related Keywords
Medtronic Evolut , Journal Of The American College Cardiology , Cardiovascular Research Foundation , Medtronic , Evolut Low Risk , Transcatheter Cardiovascular Therapeutics , American College , Low Risk Trial , Markets ,
comparemela.com © 2020. All Rights Reserved.